Related Experiment Videos

A platelet disorder due to a structural abnormality of membrane glycoprotein Ib

M Meyer1, I Schellenberg, B Hofmann

  • 1Department of Medical Genetics, Medical Academy Erfurt, GDR.

Folia Haematologica (Leipzig, Germany : 1928)
|January 1, 1988
PubMed

Insights

A genetic variant of glycoprotein Ib (GP Ib) causes mild bleeding symptoms by affecting platelet function. This abnormal GP Ib, found in carriers, alters platelet spreading and aggregation, leading to bleeding disorders.

Area of Science:

  • Hematology
  • Molecular Biology
  • Genetics

Background:

  • Platelet function is crucial for hemostasis.
  • Defects in platelet glycoproteins can lead to bleeding disorders.
  • Glycoprotein Ib (GP Ib) plays a vital role in platelet adhesion and aggregation.

Observation:

  • A patient presented with mild bleeding symptoms, reduced platelet spreading, and impaired platelet aggregation.
  • Analysis revealed an abnormal membrane glycoprotein (GP) in the patient's platelets.
  • Related carriers also exhibited this abnormal glycopeptide.

Findings:

  • The abnormal GP was identified as a genetic GP Ib variant.
  • Structurally, this variant features an increased apparent molecular weight (Mr) of the GP Ib alpha subunit.
  • The presence of this abnormal GP Ib in a heterozygous state was linked to defective platelet function.

Implications:

  • This hereditary membrane GP abnormality is causally related to the observed platelet function defect.
  • Understanding this GP Ib variant provides insights into the molecular basis of certain bleeding disorders.
  • Further research can explore diagnostic and therapeutic strategies for patients with similar platelet function abnormalities.

Related Concept Videos